A single fluconazole pill clears about nine in ten ordinary yeast infections. It does little for the pattern that returns every few weeks. Recurrent vulvovaginal candidiasis, four or more infections in a year, needs a longer plan: an induction course, then six months of weekly fluconazole, which kept 90.8 percent of women symptom-free at six months (Sobel 2004).
If you have already taken the one-pill treatment twice this season and the itching keeps coming back, the drug did its job each time. A single dose was built for a single episode, and a recurring pattern needs a different plan.
What counts as recurrent
Most people get an occasional yeast infection. Recurrent vulvovaginal candidiasis is a separate diagnosis: four or more culture-confirmed episodes in twelve months. The distinction matters because the treatment changes.
The first step for a recurrent pattern is confirming it is actually yeast. Several conditions cause similar itching and discharge, and a swab settles it. A culture also names the species. Most cases are Candida albicans, which fluconazole treats well, but a share are non-albicans species such as Candida glabrata that respond poorly to fluconazole (Sobel 2015). Someone who keeps relapsing on the right drug may have the wrong organism, and only a culture shows that.
Why one dose is not enough
The single 150 mg dose is designed to clear one uncomplicated episode, and it is non-inferior to the topical azole creams for that job (CDC STI Treatment Guidelines, 2021). What it does not do is change how susceptible you are. For someone who gets infections often, the yeast is still present weeks later, and a one-time dose leaves nothing behind to hold it down.
Severity raises the same point on a smaller scale. For a single but severe episode, two doses taken 72 hours apart clear symptoms better than one (CDC, 2021). The recurrent plan takes that logic further.
The six-month plan
The regimen studied by Sobel and colleagues, and the approach the CDC lists first for recurrent infections, has two phases. Induction clears the current infection with fluconazole 150 mg every 72 hours for three doses, on days 1, 4 and 7. Maintenance then holds it down with fluconazole 150 mg once a week for six months.
In the trial, 387 women completed induction and were randomly assigned to weekly fluconazole or placebo (Sobel et al., NEJM 2004). The results:
| Situation | Fluconazole regimen | What the evidence shows |
|---|---|---|
| Occasional, uncomplicated | 150 mg once | Clears about 90% of episodes; non-inferior to topical creams (CDC, 2021) |
| Single severe episode | 150 mg on day 1 and day 4 | Two doses improve symptom clearance over one (CDC, 2021) |
| Recurrent (4+ per year) | 150 mg days 1, 4 and 7, then 150 mg weekly for 6 months | 90.8% symptom-free at 6 months vs 35.9% on placebo (Sobel 2004) |
Median time to the next infection was 10.2 months on weekly fluconazole, against 4.0 months on placebo (Sobel 2004).
The honest limit
Suppression is not cure, and the same trial shows where the plan stops working. After the weekly pills ended at six months, the gap narrowed. At twelve months, six months after stopping, 42.9 percent of the fluconazole group remained symptom-free, against 21.9 percent on placebo (Sobel 2004). Weekly fluconazole controls recurrent infections while you take it. It does not permanently reset the tendency, and about half of women relapse within a year of stopping. That is a reason to plan the follow-up, not a reason to skip the six months.
Who the plan is not for
The recurrent regimen carries the same limits as the single dose, and a couple of new ones. Oral fluconazole is avoided in pregnancy, where a topical azole is the safe route instead. Fluconazole raises the effect of warfarin and can interact with some statins and heart-rhythm drugs, so those are reviewed before any prescription.
The single dose is on-label. The three-dose induction and the six-month weekly course are off-label and guideline-based, so a clinician reviews the history rather than approving them automatically. A recurrent pattern is also the point at which confirming the diagnosis by culture earns its keep, before committing to six months of treatment.
This article is for general information and is not medical advice. A licensed clinician reviews every request and decides what is appropriate for you. If your infections keep returning, you can start a review and discuss whether a longer plan fits.